BACKGROUND CONTEXT: The clinical entity ''discogenic back pain'' remains controversial at fundamental levels, including its pathophysiology, diagnostic criteria, and optimal treatment. This is true despite availability of four randomized trials comparing the efficacy of surgical and nonsurgical treatments. One trial showed benefit for lumbar fusion compared with unstructured nonoperative care, and three others showed roughly similar results for lumbar surgery and structured rehabilitation. PURPOSE: To compare outcomes of community-based surgical and nonsurgical treatments for patients with chronic back pain attributed to degeneration at one or two lumbar disc levels. DESIGN: Prospective observational cohort study. PATIENT SAMPLE: Patients presenting with axial back pain to academic and private practice orthopedic surgeons and neurosurgeons in a large metropolitan area. OUTCOME MEASURES: Roland-Morris back disability score (primary outcome), current rating of overall pain severity on a numerical scale, back and leg pain bothersomeness measures, the physical function scale of the short-form 36 version 2 questionnaire, use of medications for pain, work status, emergency department visits, hospitalizations, and further surgery. METHODS: Patients receiving spine surgery within 6 months of enrollment were designated as the ''surgical treatment'' group and the remainder as ''nonsurgical treatment.'' Outcomes were assessed at 3, 6, 9, and 12 months after enrollment. RESULTS: We enrolled 495 patients with discogenic back pain presenting for initial surgical consultation in offices of 16 surgeons. Eighty-six patients (17%) had surgery within 6 months of enrollment. Surgery consisted of instrumented fusion (79%), disc replacement (12%), laminectomy, The disclosure key can be found on the The Spine Journal -(2013) -or discectomy (9%). Surgical patients reported more severe pain and physical disability at baseline and were more likely to have had prior surgery. Adjusting for baseline differences among groups, surgery showed a limited benefit over nonsurgical treatment of 5.4 points on the modified (23-point) Roland disability questionnaire (primary outcome) 1 year after enrollment. Using a composite definition of success incorporating 30% improvement in the Roland score, 30% improvement in pain, no opioid pain medication use, and working (if relevant), the 1-year success rate was 33% for surgery and 15% for nonsurgical treatment. The rate of reoperation was 11% in the surgical group; the rate of surgery after treatment designation in the nonsurgical group was 6% at 12 months after enrollment.
Introduction
Back pain associated with disc degeneration may be the most controversial subject in spine care and perhaps the one most in need of further clinical research. Because chronic back pain is so disabling and so common [1, 2] , a large population of vulnerable patients is yearning for any promise of relief. These patients are attracted to an expanding range of costly diagnostic and therapeutic interventions [2, 3] . They may be unaware of the controversy surrounding many aspects of a diagnosis of ''discogenic back pain [4] .'' This diagnosis does not have wellestablished criteria. It generally refers to back pain in patients without radicular symptoms and without structural abnormalities other than lumbar disc degeneration. Professional societies provide some guidelines on this condition [5] [6] [7] [8] , but no consensus exists on whether or how to follow the recommendations [9] [10] [11] [12] . It remains unclear, for example, whether there is a localized peripheral generator of back pain [13] (ie, the intervertebral disc), whether imaging studies such as magnetic resonance imaging (MRI) [14] or diagnostic tests such as discography [15] can distinguish painful from nonpainful discs, or whether such a pain source can be eliminated by nonsurgical treatment, excision, fusion, or artificial disc replacement.
Lack of consensus regarding the efficacy of lumbar spinal fusion for discogenic back pain is particularly troubling because four European randomized trials have compared fusion with nonsurgical care [16] [17] [18] [19] . Fusion showed a small benefit for back disability compared with nonstandardized nonsurgical care but roughly similar benefit compared with intensive rehabilitation incorporating cognitive behavior therapy [20] . The Food and Drug Administration investigational device exemption artificial disc approval studies showed disc replacement to have less than 60% success rate for a composite outcome and even lower success for the comparator lumbar fusion [21] [22] [23] . In the context of rising use and costs of lumbar fusion [24, 25] , these results have invited scrutiny from payers [26, 27] . Independent evidence reviews commissioned by the Centers for Medicare and Medicaid Services Coverage and Advisory Committee [28] and the Washington Healthcare Technology Assessment Program [29] concluded that lumbar fusion for degenerative disc disease lacked sufficient evidence of efficacy and safety to justify unconditional coverage, and private payers have reached similar conclusions for artificial disc replacement [30] . In contrast, experienced surgeons claim that ''properly selected patients'' have successful outcomes with surgery, without specifying the selection criteria [31] .
The randomized trials were performed in countries with nationalized health care. We considered the possibility that patients in United States with discogenic back pain who receive surgery in a community-based practice setting may differ in important measurable characteristics from those who do not receive surgery; they may also have different outcomes. They may have different expectations, different access to services, and different social support options. Also, in a controlled trial, the strict eligibility criteria and standardized interventions may not reflect real-world practice. An observational study to describe the demographics, baseline features, and treatment use among US patients with discogenic back pain would add new and complementary information to these trials. We designed an observational prospective cohort study to address these hypotheses [32] . Our goals were to select patients presenting for initial surgical consultation for axial back pain associated with disc degeneration, select those patients the treating surgeon identified as having discogenic back pain, identify baseline characteristics associated with receiving surgery, and compare outcomes of surgical versus nonsurgical treatment. In contrast with a controlled trial, we did not interfere with the diagnosis and care process; we simply did our best to record what was done and how the patients' pain and function changed.
Methods

Study design
We conducted a prospective cohort study of patients with axial back pain seeking surgical consultation. The detailed study protocol has been previously published [32] . To obtain a representative sample of community practice, we enrolled patients from five sites: a county hospital, an academic medical center, and three community hospitals. Orthopedic surgeons (n512) and neurosurgeons (n54) participated. The study protocol was approved by the institutional review boards of University of Washington and participating community hospitals, and all study participants provided written informed consent. Study participants were followed for 12 months after enrollment.
Patient selection
Our goal was to identify patients with discogenic back pain consulting a surgeon for the first time to discuss surgical treatment options. Because no established criteria exist for this diagnosis, we relied on the judgment of the treating surgeon regarding interpretation of the patient's clinical presentation and imaging studies. We required that patients have low back pain as the primary symptom and an MRI scan confirming disc degeneration at only one or two lumbar discs. Enrollment criteria did not restrict the MRI to be within any specific time interval. The diagnosis of discogenic back pain was established by the surgeon. Investigators reviewed the radiologist's report to confirm that no specific structural abnormalities were reported by the radiologist and degeneration was limited to one or two levels. Because discography remains controversial [33] , we did not require discography as an enrollment criterion. We required symptom duration of at least 6 months, as surgeons rarely consider surgery for discogenic pain of shorter duration. We did not ask whether the pain varied during the duration interval (eg, pain everyday or most days).
Research coordinators screened records of all patients presenting with back pain at the participating sites. Coordinators used a prespecified list of exclusion criteria. Patients could be excluded at screening, baseline interview, or subsequent confirmation of enrollment criteria and consent. We excluded patients with neurological deficit or predominantly nerve root symptoms, motor deficits, abnormal electrodiagnostic studies (if performed), structural spine deformity such as stenosis or spondylolisthesis (OGrade 1), inflammatory disease, spinal malignancy, instability on radiographs (if performed), pregnancy, other specific causes for back pain, or severe comorbidity that would contraindicate surgery. We also excluded patients older than 65 years because of the high prevalence of multilevel disc degeneration and spinal stenosis in this age group.
Definition of treatment groups
In this observational study, we did not specify the treatments patients received. At each assessment, we asked patients about treatments they had received. We also recorded treatments listed in their medical records. Patients who underwent surgery within six calendar months after study enrollment date were designated as ''surgical'', and those who did not were designated as ''nonsurgical,'' even if they had surgery later in the study period. Patients could undergo multiple treatments concurrently during the study period. Any additional or concurrent nonoperative treatments received by surgical patients during the initial 6 months after enrollment were considered co-interventions.
Outcome measures
Our primary outcome was the modified Roland-Morris back disability score as measured by the number of ''yes'' responses to 23 statements describing activity limitations related to back pain [34] . Higher scores indicate greater disability. A five-point or 30% reduction from baseline score [35, 36] is considered the minimal clinically important change in this score.
Secondary outcome measures included patient current rating of overall pain severity on a numerical scale of 05''no pain'' to 105''worst possible pain,'' back and leg pain bothersomeness measures [37] [38] [39] , the physical function scale of the short-form 36 version 2 (SF-36v2) questionnaire [40] , use of medications for pain, and work status.
We also examined success rate using a composite definition of success: 30% improvement from baseline in the Roland score, 30% improvement from baseline in current pain rating, no opioid medication use within the past 3 months, and working (for patients for whom work was relevant, that is, not retired, working in the home, or receiving disability compensation before surgery).
Outcomes were assessed in person at baseline and by telephone interviews or mailed questionnaires at 3, 6, 9, and 12 months after enrollment. Interviewers were blinded to the subject's treatment group designation. Study participants were considered lost for a particular follow-up after a minimum of 12 dispersed unsuccessful telephone interview attempts and no response to 3 sequential mailings during the follow-up time window.
Baseline measures
At baseline, we assessed a variety of patient characteristics to describe the sample. These included patient sociodemographic characteristics, history of symptoms and treatments, work status, work disability compensation status, and litigation [32] . We recorded medical comorbidity using a questionnaire based on the Charlson comorbidity index [41] and asked about smoking, alcohol, and drug use [42] . Psychological measures included the symptom checklist 90 depression and somatization scales [43] , the SF-36v2, mental health scale, and the pain catastrophizing scale [44] . Psychological measures were also administered at follow-up during the first year of the study, but patient complaints of questionnaire burden required us to modify our protocol and collect these only at baseline.
Assessment of therapeutic safety
Because patients were recruited from multiple practices in this community-based study, we chose to evaluate therapeutic safety primarily through information obtained by patient interviews. We selected three adverse outcomes common to both surgical and nonsurgical treatment groups: emergency department visits, hospitalizations, and repeat surgery in the surgical group and any surgery after the treatment group designation period (first 6 months after enrollment) for the nonsurgical group. These measures were ascertained uniformly for both groups through patient interviews. We reviewed operation reports and hospital discharge summaries of the surgical patients. We also performed detailed safety surveillance of surgical patients at two hospitals [45] , but we did not have sufficient study personnel for this type of direct hospitalization surveillance of all study participants.
Statistical analysis
Our sample size calculations indicated that we needed approximately 95 patients in each treatment arm to detect a 3.0-point difference in the Roland score (primary outcome), based on a standard deviation of 7.37 from the Maine Lumbar Spine Study [38, 46] , two-sided alpha50.05, and power50.80 [32] . Because observational analyses have a strong potential for meaningful biases, we present confidence levels and sensitivity analyses for observed differences for clinically important baseline features and outcome measures.
To compare the primary outcome (1-year modified Roland score) in the two treatment groups, we used a linear mixed-effects regression model with treatment status entered as an independent variable. The model used available information to account for missing data and patients lost to follow-up. We included random effects to account for correlated measures collected on the same individuals over time with unstructured covariance. Using bivariate and multivariate logistic regression models, we examined the associations between baseline characteristics and having surgery to assess the risk of confounding in this nonrandomized study. We adjusted the linear mixed-effects model for potentially confounding baseline factors that were associated with receipt of surgery.
The inclusion of covariates for the linear mixed model using p!.05 for prediction of surgery may be too strong and exclude some other factors that are indeed associated with surgery, for which adjustment could impact estimates. Therefore, as a sensitivity measure for the primary outcome, we also performed an alternative analysis using a stepwise selection logistic regression method that included baseline variables for outcomes (Roland, SF-36 [eight domains], catastrophizing, depression, somatization, helplessness and rumination, back and leg pain), patient characteristics (gender, education, race, age, work status, back pain duration, body mass index, comorbidity, smoking, alcohol, marital status, disability, and lawyer help), and resources (days cut down on activity, bed days, missed work, prescriptions). We set the probability to remove at O.20. The following variables remained in the model: SF-36 vitality, social function, role physical, and general health domains, leg weakness, work status, cut down on activities, somatization, catastrophizing, helplessness, recruitment site, symptom duration, and previous surgery.
The number of interventions received during the treatment period was compared among groups using a trend test (ptrend in Stata). Proportions for the categorical outcome measures (safety and the composite definition of success) were compared using logistic regression with adjustment for covariates. All analyses were performed using Stata version 11.0 (StataCorp LP, College Station, TX, USA). All tests were two sided and p values !.05 were considered to be significant. Fig. 1 shows the study flow. We screened 7,344 patients who had back pain and were referred to the study. Of these, 495 met the study inclusion criteria and agreed to participate. Reasons for exclusions are listed in Table 1 . The most frequent exclusions were for age greater than 65 years (922, 13.5%), presence of radiculopathy (848, 12.4%), problem not related to lumbar spine (827, 12.1%), and prior fusion (783, 11.4%). Our sample size target was 95 in each treatment group, but after nearly 5 years of enrollment, only 86 (17%) of 495 study participants received surgery within 6 months of the enrollment date. Although more patients in the surgical group would have been optimal, we stopped further enrollment because of limits in our project funding.
Results
Study participants
Twelve-month post-enrollment interviews were completed in 70 (81%) surgical patients and 336 (82%) nonsurgical patients (Fig. 1) . Patients lost at the 12-month post-enrollment interview were significantly more likely to have baseline characteristics generally associated with worse outcomes: more prior surgery, more severe pain, greater physical disability, and more worker's compensation claims.
Baseline comparisons of surgical and nonsurgical patients
Surgical and nonsurgical patients were similar in most of the characteristics we measured at baseline, including measures of psychological distress (Table 2) . However, patient with prior lumbar decompression surgery, greater baseline back and leg pain bothersomeness, and greater back-related physical disability were more likely to receive surgery in the next 6 months ( Table 2 ). In the multivariate model, after adjusting for other important baseline characteristics, prior surgery, greater back-related physical disability, and being seen at a private practice site (as compared with an academically affiliated hospital) were associated with receiving surgery. We also found a trend toward a significantly lower chance of receiving surgery for patients who were smokers and a trend toward receiving surgery for patients with greater leg pain bothersomeness, controlling for other factors (not shown).
There was a wide range of scores on each baseline measure. On average, study participants scored almost 1 standard deviation below (ie, worse than) the general population mean on the SF-36 mental health scale, showed moderate levels of depressive symptoms, and reported multiple nonspecific physical symptoms. Mean pain-related catastrophizing scores were similar to those reported among patients seen in outpatient pain clinics [47, 48] .
Nature of the surgical treatments and co-interventions
Surgical treatment varied, consisting of instrumented fusion in 68 patients (79% of the surgical patients), artificial disc replacement in 10 (12%), and laminectomy or discectomy in 8 (9%). Enrollment criteria were confirmed in these patients; we cannot explain the rationale for decompression surgery. Surgical patients also received multiple nonsurgical co-interventions during the first 6 months after enrollment (Table 3 ). The number of nonoperative treatments was greater in the surgical group than in the nonsurgical group within the first 6 months (p5.001, Table 3 ). Surgery was performed at a mean of 2.4 months after enrollment.
Nature of nonsurgical treatments
Nonsurgical treatments received by patients during the first 6 months of the study were similar to the treatments patients reported receiving before enrollment, although rates of use were lower (Table 3) . A substantial minority of patients (13%) reported receiving no treatment during the first 6 months after enrollment, the treatment designation period for the study.
Outcomes of surgical and nonsurgical treatment
The primary outcome, back-specific disability, showed advantage for surgery (Fig. 2) . Based on linear mixed models adjusting for baseline measures associated with receipt of surgery and for loss to follow-up, patients who received surgery in the first 6 months of the study, on average, had Roland score that was 5.4 points (95% confidence interval 3.9-6.9, p!.001) lower than those of patients in the nonsurgical group at 1 year (6-12 months after surgery, mean 9.6 months after surgery).
Alternative analysis using a stepwise model suggested a slightly greater improvement in the surgical group than the original model, but this analysis was not as parsimonious, and lost some subjects because of missing baseline variables. The Roland score for the surgical group at 12 months was 6.07 points lower (95% confidence interval 4.4-7.8) compared with the nonsurgical group (p!.001), overlapping with the estimate from the original model. However, the stepwise model included many more terms and only 399 subjects because of missingness; the original model included 495 subjects and fewer parameters. The statistical tests between surgery and nonsurgery were not otherwise different, and the conclusions remain the same.
Secondary outcomes also showed advantage for surgery, including overall pain intensity rating (Fig. 2) , composite measures of success (Table 4) , and other physical and mental health measures (Table 5 ). Patients showed variable improvement on both the overall pain rating and Roland back disability scales, but the surgical group had greater improvement than the nonsurgical group at all potential cut-off thresholds for defining success (Fig. 3) . Using a composite measure of success defined as 30% improvement from baseline in the Roland score, 30% improvement from baseline in pain rating, return to work for eligible workers, and no opioid pain medication use, the 1-year postenrollment success rate was 33% in the surgery group and 15% in the nonsurgical group (p!.001, Table 4 ). Some patients did not improve: approximately 25% of nonsurgical and 15% of surgical patients reported worse function and increased pain at 12 months after enrollment compared with baseline (Fig. 3) .
Patient-reported measures of safety
Between 6 and 12 months after enrollment, emergency department visits occurred with similar frequency in the two treatment groups: 5/76 (7%) of surgical patients and 41/366 (11%) nonsurgical patients (p5.23). Overnight hospitalizations also occurred with similar frequency in both groups: 1/76 (1%) surgical and 13/366 (4%) nonsurgical (p5.31). Repeat surgery occurred in 8/76 (11%) of surgical patients. Also, 22/366 (6%) of patients in the nonsurgical group received surgery between 6 and 12 months after enrollment.
Discussion
This community-based comparative effectiveness study showed only fair outcomes for both surgical and nonsurgical treatments of discogenic back pain. Patients with chronic back pain who seek surgical consultation and are found to have discogenic back pain presented, on average, with moderate levels of pain, physical disability, and psychological distress. When assessed 12 months after enrollment, patients who had surgery combined with nonsurgical co-interventions showed modest but significantly greater improvement in self-reported disability, back pain, generic physical function, and composite success measures compared with patients who had continuation of unstructured nonsurgical care. Surgical patients also concurrently received more intensive cotreatments than the nonsurgical group. Although surgery combined with various additional nonsurgical treatments showed advantage over nonsurgical treatment alone, only one-third of surgical patients attained a successful result defined by stringent criteria of clinically important improvement in pain and function, no opioid medication use, and return to work for eligible workers. The rate of activity restriction and opioid use was significantly greater in the surgical group along with greater use of corsets and bed rest. Surgery did not reduce the frequency of emergency room visits or overnight hospitalizations, and 11% of patients had repeat surgery within the first year postoperatively.
Patients, on average, showed minimal improvement after 12 months of continued nonsurgical care as currently provided in the United States. Nonsurgical treatments that the patients received varied widely, were used in an unstructured manner, and mostly did not comply with conservative care guidelines. For example, only 5% received cognitive behavior therapy. Outcomes in the nonsurgical group may have improved more if treatment had adhered to recommendations from clinical practice guidelines [6] .
The poor prognosis we observed for discogenic back pain has policy implications. The nonsurgical patients in our study provide somewhat of a natural history of discogenic back pain because they received minimal new therapy after enrollment. In contrast with the commonly held view that nonspecific back pain has a benign course, those who sought surgical consultation had marked pain and functional limitations at enrollment and remained essentially unchanged during 12 subsequent months of surveillance.
The fundamental concepts underlying the mechanism of pain in these patients, the treatment options offered to them, and policies governing these treatments need re-evaluation. New diagnostic and surgical technologies are readily NA, not applicable. * Subjects were asked if they received the treatment at any time in the past before enrollment. y The initial 6 months after enrollment was the time interval during which treatment group designation was determined. Those patients who received surgery during that period comprised the surgical group. Values indicate any endorsement of that treatment at either the 3-or the 6-month postenrollment assessment. Fig. 2 . Adjusted and unadjusted Roland disability (primary outcome) and back pain intensity at each follow-up time point measured from enrollment date. available in community practice, but comprehensive rehabilitation and cognitive behavior therapy are difficult to find and frequently not covered by insurance programs.
We conducted an observational study to obtain a ''realworld'' or pragmatic view of community-based practice and outcomes for discogenic back pain. We acknowledge that observational studies comparing treatment effectiveness have many limitations; results should be interpreted with caution. Despite statistical adjustments, unmeasured confounding factors persist and bias observed associations. The population chosen for this study was likely biased in favor of surgery because it had already made the decision to seek a surgical consultation. Only a small fraction of patients with back pain seeking surgical opinion were judged by the treating surgeon to have discogenic back pain (ie, chronic back pain, disc degeneration at only one or two lumbar levels, and no other focal abnormalities).
In contrast with the standardization often imposed in randomized trials, this study shows that under natural conditions, patients with chronic back pain often mix multiple treatment interventions concurrently. Surgical patients simultaneously received multiple nonsurgical co-interventions. In fact, patients who underwent surgery received more nonoperative treatments than did patients in the nonsurgical group. We enrolled patients after the studies by Fritzell et al. [19] and Brox et al. [17] were published. During orientation of surgeons participating in our study, we reviewed that data showing intensive rehabilitation incorporating cognitive behavior therapy were just as effective as surgery [20] . Despite availability of this knowledge, the nonsurgical care received by patients in our study remained haphazard.
Our study reports early short-term results. Follow-up for surgical patients averaged 9.6 months postoperatively. Lumbar arthrodesis procedures can require that duration for healing, placebo effects may be particularly strong in the early postoperative period [49] , and the advantage for surgery may diminish with time. Surgical advantage was greatest at 1 year and diminished by 2 years in a Swedish randomized trial comparing lumbar fusion to nonoperative care [19] ; outcomes for surgical and nonsurgical groups were similar at 5-year follow-up [50] . A small Japanese trial also showed early advantage for surgery [51] .
Although it is widely accepted that back pain in some patients may be caused by lumbar disc degeneration, the diagnosis of discogenic back pain lacks a firm biological basis and clear clinical description. It is uncertain whether the structural and physiological intervertebral disc changes associated with aging alone can be distinctly separated from changes that cause low back pain. Because disc degeneration is almost ubiquitous beyond the age of 50 years and because back pain is very common, this ambiguity has important clinical implications. Some physicians believe that individual discs can be identified as sources of pain in individual patients and infer that surgery to immobilize or replace the disc will help eliminate back pain [52] . Others believe it is nearly impossible to identify specific discs as a cause of pain in individual patients [52] . A Combined Task Force of the North American Spine Society, American Society of Spine Radiology, and American Society of Neuroradiology for Nomenclature and Classification of Lumbar Disc Pathology acknowledged the difficulty of distinguishing disc degeneration from normal aging [53] .
Efficacy cannot be proven by nonrandomized studies such as ours [54] . We address group differences by reporting multiple comparisons of baseline measures, interventions, and outcomes. However, confounding by unmeasured factors may account for the associations observed between surgery and outcomes. Surgical patients in our study also received more intensive nonoperative co-interventions compared with the nonsurgical cohort, none of whom received structured state-of-the-art rehabilitation, and some received no treatment. However, if patient preferences, the treating surgeon's patient selection biases, co-interventions, and other unmeasured factors associated with receiving surgery are considered as a bundled package (ie, ''use effectiveness'' [55] ), surgical patients had better-but still poor-outcomes compared with continued unstructured nonsurgical care.
Our study shows that patients whom a spine surgeon labeled as having discogenic back pain have severe functional limitations at baseline, have multiple comorbidities, and receive multiple concurrent treatments in the course of usual care. In contrast with the general perception that patients with nonspecific back pain improve with minimal treatment, we found these patients continue to have severe y Excluding those patients who at baseline reported being a student, homemaker, retired, or on permanent disability.
pain and functional limitations. The degree of improvement we observed in surgical patients was marginal despite intensive concurrent treatments. These findings are relevant to guiding policy and practice for this patient population in the United States. Facilitating effective treatments based on trustworthy clinical practice guidelines may yield large benefits at the population level.
Access to patient-level data
The Center for Surgical Innovation at Dartmouth (CSI) website (http://dartmouth-hitchcock.org/csi) will provide de-identified study data to any researchers interested in evaluating new hypotheses or confirming hypotheses within this paper, or professors wishing to use the database for classroom purposes. The website provides the data dictionary for the study cohort, an accompanying document that describes the data structure, and general guidelines regarding how to request the data. The Methodology Core for the Dartmouth/NIH NIAMS Multidisciplinary Clinical Research Center for Musculoskeletal Diseases (MCRC) will evaluate submitted applications and, when necessary, work with the applicants to clarify the project aims. Upon approval, the MCRC will provide the applicant with a secure data set that includes all of the variables the researchers and the MCRC evaluation committee determine are necessary and a data entry program in the statistical package (SAS, STATA, SPSS, or R) selected by users. The CSI website will track the number of applicant requests, projects that have been summited, projects that have been approved, the project title and involved researchers for approved CI, confidence interval; SF-36v2, short-form 36 version 2; SCL-90, symptom checklist 90. * Controlling for age, sex, education, previous surgery, alcohol use, smoking, body mass index, race, work status, Charlson comorbidity index, overall pain intensity, back pain bothersome, leg pain bothersome, symptom duration, and study recruitment site.
projects, and, once completed, a structured abstract of the project.
